SLL

ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?
Fierce Pharma
Fri, 05/26/23 - 09:57 am
ASCO 2023
Bristol Myers Squibb
Breyanzi
CAR-T
CLL
SLL
clinical trials
AbbVie, J&J blockbuster Imbruvica rakes in 11th FDA approval, as competitors work on eroding franchise
Endpoints
Wed, 04/22/20 - 10:43 am
AbbVie
JNJ
Imbruvica
FDA
CLL
SLL
AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
BioSpace
Mon, 11/25/19 - 09:46 am
AstraZeneca
FDA
CLL
SLL
Calquence
AbbVie submits sNDA to FDA for IMBRUVICA, Rituximab combo for CLL
Pharmaceutical Business Review
Mon, 11/11/19 - 10:58 am
AbbVie
Imbruvica
rituximab
CLL
SLL
Priority Review for Imbruvica-Gazyva combo to treat CLL, SLL
BioCentury
Wed, 10/17/18 - 12:24 pm
AbbVie
FDA
priority review
Imbruvica
Gazyva
CLL
SLL